Nkarta selected for ACR Convergence 2026 autoimmune NKX019 presentations
Nkarta said it was selected for three scientific presentations at ACR Convergence 2026, where it will present initial autoimmune clinical data for NKX019.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.